EP2645860A4 - Nitric oxide treatments - Google Patents

Nitric oxide treatments

Info

Publication number
EP2645860A4
EP2645860A4 EP11844660.8A EP11844660A EP2645860A4 EP 2645860 A4 EP2645860 A4 EP 2645860A4 EP 11844660 A EP11844660 A EP 11844660A EP 2645860 A4 EP2645860 A4 EP 2645860A4
Authority
EP
European Patent Office
Prior art keywords
nitric oxide
oxide treatments
treatments
nitric
oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11844660.8A
Other languages
German (de)
French (fr)
Other versions
EP2645860A1 (en
Inventor
David H Fine
Robert F Roscigno
Gregory Vasquez
Bryan Johnson
Ryan Denton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vero Biotech LLC
Original Assignee
Geno LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geno LLC filed Critical Geno LLC
Priority to EP17206023.8A priority Critical patent/EP3360557A3/en
Publication of EP2645860A1 publication Critical patent/EP2645860A1/en
Publication of EP2645860A4 publication Critical patent/EP2645860A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP11844660.8A 2010-12-03 2011-12-02 Nitric oxide treatments Withdrawn EP2645860A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP17206023.8A EP3360557A3 (en) 2010-12-03 2011-12-02 Nitric oxide treatments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41965710P 2010-12-03 2010-12-03
PCT/US2011/063117 WO2012075420A1 (en) 2010-12-03 2011-12-02 Nitric oxide treatments

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP17206023.8A Division EP3360557A3 (en) 2010-12-03 2011-12-02 Nitric oxide treatments

Publications (2)

Publication Number Publication Date
EP2645860A1 EP2645860A1 (en) 2013-10-09
EP2645860A4 true EP2645860A4 (en) 2014-07-09

Family

ID=46172292

Family Applications (2)

Application Number Title Priority Date Filing Date
EP17206023.8A Withdrawn EP3360557A3 (en) 2010-12-03 2011-12-02 Nitric oxide treatments
EP11844660.8A Withdrawn EP2645860A4 (en) 2010-12-03 2011-12-02 Nitric oxide treatments

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP17206023.8A Withdrawn EP3360557A3 (en) 2010-12-03 2011-12-02 Nitric oxide treatments

Country Status (5)

Country Link
EP (2) EP3360557A3 (en)
JP (3) JP2014506872A (en)
AU (1) AU2011336358B2 (en)
CA (1) CA2819854A1 (en)
WO (1) WO2012075420A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014527025A (en) * 2011-05-27 2014-10-09 ゲノ エルエルシー Method for determining vascular reactivity using inhaled nitric oxide
JP2016500550A (en) * 2012-11-05 2016-01-14 ゲノ エルエルシー Method for mixing a gas containing nitric oxide
EP3970730B1 (en) * 2016-02-12 2024-05-01 Mallinckrodt Pharmaceuticals Ireland Limited System for use and monitoring of inhaled nitric oxide with left ventricular assist devices
JP2020510499A (en) * 2017-02-27 2020-04-09 サード ポール, インコーポレイテッドThird Pole, Inc. Mobile production system and method for nitric oxide
EP3634554B1 (en) 2017-06-08 2023-11-08 Case Western Reserve University Vaporization system for delivery in a controlled concentration
MX2020001853A (en) * 2017-08-25 2020-08-03 Mallinckrodt Hospital Products Ip Ltd Methods to improve organ viability.
AU2018323547A1 (en) * 2017-08-30 2020-02-13 Bellerophon Pulse Technologies Llc Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
KR20200127158A (en) * 2017-12-28 2020-11-10 벨레로폰 펄스 테크놀로지스 엘엘씨 Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020251A1 (en) * 1997-10-21 1999-04-29 The General Hospital Corporation Use of inhaled no as anti-inflammatory agent
US20110259325A1 (en) * 2010-04-26 2011-10-27 Geno Llc Delivery of ultra pure nitric oxide (NO)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728705A (en) * 1993-10-04 1998-03-17 The Trustees Of Columbia University In The City Of New York Method of inducing vasorelaxation to treat pulmonary hypertension
EP1267862A2 (en) * 2000-02-22 2003-01-02 Cellegy Canada Inc. Methods and compositions for improving sleep
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
AU2002336401A1 (en) 2001-09-05 2003-03-18 Cyterra Corporation Nitric oxide generation
GB0326047D0 (en) * 2003-11-07 2003-12-10 Univ Sheffield Substance
WO2005060603A2 (en) * 2003-12-10 2005-07-07 Nitromed, Inc. Nitric oxide releasing pyruvate compounds, compositions and methods of use
JP4336602B2 (en) 2004-03-29 2009-09-30 津田駒工業株式会社 Inclined rotary table for machine tools
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
CA2576957C (en) * 2004-08-18 2013-04-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
EP1781254A2 (en) * 2004-08-23 2007-05-09 Mannkind Corporation Pulmonary delivery of inhibitors of phosphodiesterase type 5
AU2008232413B2 (en) 2007-03-23 2013-09-19 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2009097343A1 (en) 2008-01-28 2009-08-06 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
CA2730011C (en) 2008-07-24 2019-05-07 Geno Llc Methods for diagnosing and treating a heart condition in a patient
US8701657B2 (en) 2008-08-21 2014-04-22 Geno Llc Systems for generating nitric oxide
US10960168B2 (en) 2008-08-21 2021-03-30 Vero Biotech LLC Delivery of high concentration nitric oxide
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US10780241B2 (en) 2008-08-21 2020-09-22 Vero Biotech LLC Devices and methods for minimizing and treating high-altitude sickness
AU2009292963B2 (en) * 2008-09-22 2016-08-18 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
EP2501427B1 (en) 2009-11-20 2018-03-21 Geno LLC Nitric oxide delivery system
EP2531249B1 (en) 2010-02-01 2021-03-24 VERO Biotech LLC Nitric oxide delivery system
WO2011119706A1 (en) 2010-03-26 2011-09-29 E.I. Dupont De Nemours And Company Perhydrolase providing improved specific activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020251A1 (en) * 1997-10-21 1999-04-29 The General Hospital Corporation Use of inhaled no as anti-inflammatory agent
US20110259325A1 (en) * 2010-04-26 2011-10-27 Geno Llc Delivery of ultra pure nitric oxide (NO)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KUKITA ICHIRO ET AL: "Inhaled nitric oxide followed by extracorporeal membrane oxygenation in resuscitating a newborn with hypoxemia", ACTA PAEDIATRICA JAPONICA, vol. 40, no. 1, February 1998 (1998-02-01), pages 91 - 92, XP008169617, ISSN: 0374-5600 *
MINAMISHIMA S ET AL: "Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice", CIRCULATION 20111011 LIPPINCOTT WILLIAMS AND WILKINS USA, vol. 124, no. 15, 11 October 2011 (2011-10-11), pages 1645 - 1653, XP008169642, ISSN: 0009-7322 *
See also references of WO2012075420A1 *

Also Published As

Publication number Publication date
JP2017061513A (en) 2017-03-30
WO2012075420A1 (en) 2012-06-07
CA2819854A1 (en) 2012-06-07
EP2645860A1 (en) 2013-10-09
JP2019108335A (en) 2019-07-04
EP3360557A3 (en) 2018-11-07
AU2011336358B2 (en) 2016-09-29
AU2011336358A1 (en) 2013-06-27
EP3360557A2 (en) 2018-08-15
JP2014506872A (en) 2014-03-20

Similar Documents

Publication Publication Date Title
EP2445508A4 (en) Nitric oxide therapies
GB201016925D0 (en) Graphene oxide
TWI562235B (en) Feature size reduction
EP2531249A4 (en) Nitric oxide delivery system
GB201421114D0 (en) Nitric oxide generator and inhaler
PL2652193T3 (en) Treatment
ZA201205425B (en) Treatment with vb-201
EP2645860A4 (en) Nitric oxide treatments
EP2830698A4 (en) Nitric oxide delivery devices
EP2575829A4 (en) Kit for the treatment of onychomycosis by nitric oxide
EP2624851A4 (en) Moesin fragments and uses thereof
HK1183626A1 (en) Keloid treatment
EP2602616A4 (en) Nitric oxide detector element
EP2697386A4 (en) Pepducin design and use
EP2658972A4 (en) Melanoma treatments
EP2567667A4 (en) Treatment tool
EP2532314A4 (en) Treatment tool
EP2615328A4 (en) Reduction device
EP2560677A4 (en) Cold treatment
GB201013573D0 (en) Treatment
EP2940699A4 (en) Oxide superconductor wire
GB201014097D0 (en) Treatment
EP2716634A4 (en) Triazole compound and use thereof
TWM389248U (en) Crossbow which can be used safely
AU4935P (en) FerrupenGL Pimelea ferruginea

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130702

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20140606

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 33/00 20060101ALI20140602BHEP

Ipc: A61P 11/00 20060101ALI20140602BHEP

Ipc: A01N 59/00 20060101AFI20140602BHEP

17Q First examination report despatched

Effective date: 20151021

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20171208